Zurueck zur Suche

Reporte zur Charge UJ540AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 2 OR 2 UT 1 NH 1

VAERS 1813142

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ540AA

gering
Staat
OH
Alter
72,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
27.09.2021
Beginn
27.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

A patient was received an expired dose of vaccine no AE; Initial information regarding an unsolicited valid non-serious case was received from other Health Care Professional via a consumer/non-health care professional via Global Medical Information (GMI) (Reference number- 00817294) and transmitted to Sanofi on 18-Oct-2021. This case is linked to case 2021SA347320 (same reporter). This case involves a 72-year-old female patient who was received an expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (Expired product administered). The patient's medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 27-Sep-2021, the patient received a 0.7 mL dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ540AA, expiry: 30-Jun-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was a case of an actual medication error due to Expired vaccine used (latency same day). It was reported "Clinical supervisor states they gave FLUZONE high dose (HD) QUADRIVALENT to a patient in September and it was expired. Do they give another dose or what does she do? The caller reported that a husband and wife received expired doses on the same day." No other event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out by the regulatory authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813141

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ540AA

gering
Staat
OH
Alter
74,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
27.09.2021
Beginn
27.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

received expired doses with no reported adverse event; Initial information received on 18-Oct-2021 regarding an unsolicited valid non-serious case received from an other health professional via Global Media Information (under the reference 00817263). This case is linked to case 2021SA348292 (case for wife). This case involves a 74 years old male patient who received expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (expired product administered). The patient's medical history, medical treatment(s), concomitant medication(s) and family history were not provided. Patient had no other vaccines. On 27-Sep-2021, the patient received a dose of suspect FLUZONE HIGH-DOSE QUADRIVALENT (0.7 ml, total, once, lot UJ540AA and expiration date: 30-Jun-2021) via intramuscular route in the right deltoid for prophylactic vaccination. I was an actual medication error due to expired product administered (same day latency). No adverse event reported. At time of reporting, the outcome was unknown for the reported event. It was reported "Clinical supervisor states they gave FLUZONE HD QUAD to a patient in September and it was expired. Do they give another dose or what does she do? The caller reported that a husband and wife received expired doses on the same day." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out by the regulatory authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1060247

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj540aa

gering
Staat
OR
Alter
84,0
Geschlecht
F
Eingang
27.02.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

patient requested covid vaccine, flu vaccine given in error instead

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1060244

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj540aa

gering
Staat
OR
Alter
84,0
Geschlecht
M
Eingang
27.02.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

incorrect vaccine given, patient request covid vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1059982

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj540aa

gering
Staat
UT
Alter
82,0
Geschlecht
M
Eingang
27.02.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient received FluBlok on 10/1/2020 and received a duplicate flu shot for the season of Fluzone HD on 2/27/2021. I called patient and they were asymptomatic when I spoke with them and urged them to seek medical care should they begin to feel any worse.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension, Hyperlipidemia
Andere Medikamente
Amlodipine, Atorvastatin, Lisinopril, Metoprolol,
Allergien
-
Vorherige Impfungen
-

VAERS 918153

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ540AA

gering
Staat
NH
Alter
-
Geschlecht
F
Eingang
04.01.2021
Impfdatum
08.10.2020
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

receiving FLUZONE HIGH DOSE QUADRIVALENT when patient already received Fluad vaccine with no AE; had intended on getting the pneumonia vaccine, she already had a flu vaccine with no AE; Initial information received on 10-Dec-2020 regarding an unsolicited valid non-serious case from a pharmacist. This case involves a 68 years old female patient who received fluzone high dose quadrivalent when patient already received fluad vaccine (extra dose administered) and had intended on getting the pneumonia vaccine, she already had a flu vaccine (wrong product administered), while she received vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT], INFLUENZA VACCINE INACT SAG 3V [FLUAD] and PNEUMOCOCCAL VACCINE. The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. No concomitant medication was reported. On 08-Oct-2020, the patient received suspect FLUAD (INFLUENZA VACCINE INACT SAG 3V) with an unknown dose, route, frequency, strength and formulation for prophylactic vaccination. On 12-Oct-2020, the patient received 0.7 ml to 2 ml once a day dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE via intramuscular route in right arm (lot number: UJ540AA and expiry date: 30-Jun-2021) for prophylactic vaccination. On an unknown date, the patient received PNEUMOCOCCAL VACCINE with an unknown dose, route, frequency, strength and formulation for prophylactic vaccination. On an unknown date (latency unknown), the patient received FLUZONE HIGH DOSE QUADRIVALENT when the patient already received FLUAD vaccine (extra dose administered) and pharmacist stated that the patient came in to the pharmacy and requested a Flu vaccine. She filled out the consent form and checked the influenza vaccine box. Then, after she received it, she asked the pharmacist if that was the 23 that she had received. The patient had intended on getting the pneumonia vaccine, she already had a flu vaccine in October (year unknown) (wrong product administered). This was an actual medication error due to extra dose administered and wrong vaccine administered. No laboratory data reported. At the time of reporting, no adverse event was reported to the patient. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-